[Progress on clinical and etiological study of NIDDM].
Seino
H
H
D000255:Adenosine Triphosphate / Q000502:physiology; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology* / Q000628:therapy; D004035:Diet Therapy; D005081:Exercise Therapy; D005260:Female; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D000255:Adenosine Triphosphate; D006003:Glycogen